This study is to find out if the Attention Processing Training program is a potentialtreatment for brain fog symptoms, reported by people with Long-Covid. Also investigatingthe feasibility of completing this program virtually.
The goal of this project is to test the feasibility, acceptability and efficacy of an
attention training intervention (Attention Process Training; APT-3) as a potential
treatment for brain fog symptoms experienced by people with Long-Covid. There already is
good empirical evidence to support the idea that the APT-3 treatment is feasible and
effective in improving attention in people with acquired brain injuries, but information
about its efficacy and acceptability in people with Long-Covid brain fog is lacking.
Other: Attention Training
The APT-3 is an evidence-based, standardized computer-based training program that was
designed to improve attention skills that underlie higher level cognitive processes
(e.g., executive functions and memory).
Other Name: APT-3
Other: Music Group
This group will listen to a pre-determined playlist of music following the same dosing as
the attention training group as stated in the arms.
Inclusion Criteria:
- Aged 18-65 years. Live in the Chicagoland area
- A history of confirmed SARS-CoV-2 infection.
- Subjective reports of cognitive symptoms that interfere with everyday activities,
starting on or shortly after SARS-CoV-2 infection.
- Continuation or development of Long-Covid brain fog 3 months after the initial
SARS-CoV-2 infection, with these symptoms lasting for at least 2 months with no
other explanation.
- Objective attentional deficits as measured by the Conners CPT-312, and/or the Digit
Span subtest (WAIS- III13).
- Able to use a keyboard.
- Able to understand and communicate in English.
- Able to consent independently.
Exclusion Criteria:
- Being hospitalized due to COVID-19 diagnosis for more than 3 days.
- Pre-morbid neurological conditions that could potentially affect cognition, such as
Parkinson's Disease, Alzheimer's Dementia, acquired brain injury.
- Severe depression.
- Currently enrolled in cognitive training or physical exercise training.
- Receiving chemotherapy or radiation within last 6 months.
- Active substance abuse.
Shirley Ryan AbilityLab
Chicago 4887398, Illinois 4896861, United States
Investigator: Kathryn L Magee
Contact: 312-238-6451
Longcovid@sralab.org
Kathryn Magee, MHS
(312)238-6451
LongCovid@sralab.org